Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Ruggiu

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2018
Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort StudyMathilde Ruggiu, Pierre Bedossa, Pierre Emmanuel Rautou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2020
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?Mathilde Ruggiu, Bruno Cassinat, Jean-Jacques Kiladjian, et al.
Bone Marrow Transplantation|May 25, 2024
Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigensAliénor Xhaard, Aline Floch, Mathilde Ruggiu, et al.
The Journal of Clinical Investigation|July 19, 2013
Transcription factor EGR1 directs tendon differentiation and promotes tendon repairMarie-Justine Guerquin, Benjamin Charvet, Geoffroy Nourissat, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 6, 2025
Transfusion strategy and allo-immunization to red blood cell antigens after allogeneic hematopoietic stem cell transplantation with partial donor/recipient Rh matchingJeromine Beaufort, Alienor Xhaard, Aline Floch, et al.
Leukemia & Lymphoma|November 29, 2017
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemiaMathilde Ruggiu, Florence Oberkampf, David Ghez, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2018
Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort StudyMathilde Ruggiu, Pierre Bedossa, Pierre Emmanuel Rautou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2020
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?Mathilde Ruggiu, Bruno Cassinat, Jean-Jacques Kiladjian, et al.
Bone Marrow Transplantation|May 25, 2024
Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigensAliénor Xhaard, Aline Floch, Mathilde Ruggiu, et al.
The Journal of Clinical Investigation|July 19, 2013
Transcription factor EGR1 directs tendon differentiation and promotes tendon repairMarie-Justine Guerquin, Benjamin Charvet, Geoffroy Nourissat, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 6, 2025
Transfusion strategy and allo-immunization to red blood cell antigens after allogeneic hematopoietic stem cell transplantation with partial donor/recipient Rh matchingJeromine Beaufort, Alienor Xhaard, Aline Floch, et al.
Leukemia & Lymphoma|November 29, 2017
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemiaMathilde Ruggiu, Florence Oberkampf, David Ghez, et al.
Pageof 2